Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease characterised by
worsening respiratory symptoms and physiological impairment. Increasing awareness of the …

Evidence suggests that lung injury, inflammation and extracellular matrix remodelling
precede lung fibrosis in interstitial lung disease (ILD). We examined whether a quantitative …

Rationale: Several common and rare genetic variants have been associated with idiopathic
pulmonary fibrosis, a progressive fibrotic condition that is localized to the lung. Objectives: …

Rationale: Interstitial lung abnormalities (ILAs) are associated with the highest genetic risk
locus for idiopathic pulmonary fibrosis (IPF); however, the extent to which there are unique …

Rationale: Obstructive sleep apnea (OSA) has been postulated to contribute to idiopathic
pulmonary fibrosis by promoting alveolar epithelial injury via tractional forces and intermittent …

… Correspondence and requests for reprints should be addressed to Anna J. Podolanczuk,
MD, MS, Department of Medicine, Columbia University Medical Center, 622 West 168th Street, …

The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–induced
coronavirus disease (COVID-19) dominated the year 2020. Initial reports of the long-term …

Rationale: The impact of a broad range of occupational exposures on subclinical interstitial
lung disease (ILD) has not been studied. Objectives: To determine whether occupational …

Idiopathic pulmonary fibrosis (IPF) currently affects about 100 000 individuals in the US, and
millions globally. Patients living with IPF experience disabling symptoms and progressive …

Objectives There is little in-depth qualitative evidence of how symptoms manifest themselves
in outpatients with COVID-19 and how these in turn impact outpatients’ daily lives. The …